Insulin inhibition of platelet-endothelial interaction is mediated by insulin effects on endothelial cells without direct effects on platelets
Open Access
- 12 February 2008
- journal article
- research article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 6 (5), 856-864
- https://doi.org/10.1111/j.1538-7836.2008.02925.x
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Soluble Guanylyl Cyclase Activation With HMR1766 Attenuates Platelet Activation in Diabetic RatsArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Critical nodes in signalling pathways: insights into insulin actionNature Reviews Molecular Cell Biology, 2006
- Reduced Vascular NO Bioavailability in Diabetes Increases Platelet Activation In VivoArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- AMP-activated protein kinase (AMPK) regulates the insulin-induced activation of the nitric oxide synthase in human plateletsThrombosis and Haemostasis, 2003
- A Dominant-negative p38 MAPK Mutant and Novel Selective Inhibitors of p38 MAPK Reduce Insulin-stimulated Glucose Uptake in 3T3-L1 Adipocytes without Affecting GLUT4 TranslocationPublished by Elsevier BV ,2002
- Endothelial dysfunction in diabetesBritish Journal of Pharmacology, 2000
- Increased Adhesion and Aggregation of Platelets Lacking Cyclic Guanosine 3′,5′-Monophosphate Kinase IThe Journal of Experimental Medicine, 1999
- Recombinant insulin-like growth factor-1 modulates aggregation in human platelets via extracellular calciumLife Sciences, 1996
- Nitric oxide release accounts for insulin's vascular effects in humans.JCI Insight, 1994
- Insulin induced phosphorylation and activation of the cGMP-inhibited cAMP phosphodiesterase in human plateletsBiochemical and Biophysical Research Communications, 1992